Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enzon Pharma Inc (ENZN)

Enzon Pharma Inc (ENZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 41,553
  • Shares Outstanding, K 74,215
  • Annual Sales, $ 50 K
  • Annual Income, $ -1,310 K
  • 60-Month Beta 0.56
  • Price/Sales 856.33
  • Price/Cash Flow N/A
  • Price/Book 6.96
Trade ENZN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/29/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.240 on 09/30/19
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4800 +6.25%
on 04/20/21
0.8300 -38.55%
on 03/22/21
-0.2900 (-36.25%)
since 03/19/21
3-Month
0.3450 +47.83%
on 02/10/21
0.8500 -40.00%
on 02/08/21
+0.0875 (+20.71%)
since 01/21/21
52-Week
0.0200 +2,450.00%
on 10/01/20
0.8500 -40.00%
on 02/08/21
+0.3595 (+238.87%)
since 04/21/20

Most Recent Stories

More News
Anti-Fungal Agents Market Technology, New Innovations, Future Guidelines, Key Players, Trends and Forecast 2021 - 2028 By Ameco Research

pune, India, Wed, 21 Apr 2021 05:11:42 / Comserve Inc. / -- Ameco Research has revealed its most recent report on "Anti-Fungal Agents Market" that processes industry development pattern through previous...

ALPMF : 14.6700 (-2.20%)
BAYRY : 16.7200 (+2.26%)
ENZN : 0.5100 (-8.91%)
GSK : 38.17 (+1.25%)
MRK : 79.24 (+0.85%)
NVS : 88.67 (+0.96%)
VRX.TO : 30.80 (-3.33%)
Anti-Fungal Agents Market Growth, Latest Trend and Forecast 2021 - 2028 By Ameco Research

pune, India, Wed, 07 Apr 2021 23:37:44 / Comserve Inc. / -- The global Anti-Fungal Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other...

ALPMF : 14.6700 (-2.20%)
BAYRY : 16.7200 (+2.26%)
ENZN : 0.5100 (-8.91%)
GSK : 38.17 (+1.25%)
MFAC : 14.76 (-0.74%)
MRK : 79.24 (+0.85%)
NVS : 88.67 (+0.96%)
VRX.TO : 30.80 (-3.33%)
Global Anti-Fungal Agents Market 2020 Growth Factors, Product Overview, Segmentation and Forecast Study to 2025

is a resource, which provides current as well as upcoming technical and financial details of the industry. The report analyzes and determines the effect of the external factors which are impacting the...

ALPMF : 14.6700 (-2.20%)
ENZN : 0.5100 (-8.91%)
MRK : 79.24 (+0.85%)
NVS : 88.67 (+0.96%)
VRX.TO : 30.80 (-3.33%)
Antifungal Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to value over USD 19.7 billion by 2027 end at a CAGR of over 3.7% during the forecast period 2020 to 2027.

ABT : 120.87 (+0.73%)
ALPMF : 14.6700 (-2.20%)
BAYRY : 16.7200 (+2.26%)
ENZN : 0.5100 (-8.91%)
GILD : 66.66 (+0.42%)
GSK : 38.17 (+1.25%)
MRK : 79.24 (+0.85%)
NVS : 88.67 (+0.96%)
VRX.TO : 30.80 (-3.33%)
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO

Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Company's Chief Executive Officer effective February 26,...

ENZN : 0.5100 (-8.91%)
Enzon Pharmaceuticals Announces Results of Rights Offering

Enzon Pharmaceuticals, Inc. (the "Company" or "Enzon") (OTC:ENZN) announced the results of its rights offering following the expiration of the subscription period on October 9, 2020 at 5:00 p.m. New York...

ENZN : 0.5100 (-8.91%)
Enzon Pharmaceuticals Announces Key Dates for Rights Offering

Enzon Pharmaceuticals, Inc. (the "Company" or "Enzon") (OTC:ENZN) announced today the record date and expected subscription period for its previously-announced rights offering to raise proceeds of approximately...

ENZN : 0.5100 (-8.91%)
Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

Enzon Pharmaceuticals, Inc. (the "Company" or "Enzon") (OTC:ENZN) today announced that its 2020 annual meeting of stockholders (the "Annual Meeting") originally scheduled to be held on Thursday, September...

ENZN : 0.5100 (-8.91%)
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

Enzon Pharmaceuticals, Inc. (the "Company" or "Enzon") (OTC: ENZN) today announced that its Board of Directors (the "Board") has approved a rights offering to existing shareholders whereby the Company...

ENZN : 0.5100 (-8.91%)
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

Enzon Pharmaceuticals, Inc. (the "Company" or "Enzon") (OTC:ENZN) today announced that its Board of Directors (the "Board") adopted a tax benefits preservation plan (the "Section 382 Rights Plan") designed...

ENZN : 0.5100 (-8.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.7833
2nd Resistance Point 0.7066
1st Resistance Point 0.6333
Last Price 0.5100
1st Support Level 0.4833
2nd Support Level 0.4066
3rd Support Level 0.3333

See More

52-Week High 0.8500
Fibonacci 61.8% 0.5329
Last Price 0.5100
Fibonacci 50% 0.4350
Fibonacci 38.2% 0.3371
52-Week Low 0.0200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar